Targeting gut microbiota as a novel strategy for prevention and treatment of hypertension, atrial fibrillation and heart failure: current knowledge and future perspectives

OM Drapkina, AA Yafarova, AN Kaburova, AR Kiselev - Biomedicines, 2022 - mdpi.com
Cardiovascular diseases (CVDs) remain the major public health concern worldwide. Over
the last two decades, a considerable amount of literature has been published on gut …

The role of genetic and epigenetic regulation in Intestinal Fibrosis in Inflammatory Bowel Disease: a descending process or a programmed consequence?

S Jarmakiewicz-Czaja, A Sokal, K Ferenc, E Motyka… - Genes, 2023 - mdpi.com
Inflammatory bowel diseases (IBDs) are a group of chronic diseases characterized by
recurring periods of exacerbation and remission. Fibrosis of the intestine is one of the most …

Akkermansia muciniphila participates in the host protection against helminth-induced cardiac fibrosis via TLR2

J Wang, X Liu, R Sun, H Mao, M Liu, X Jin - PLoS pathogens, 2023 - journals.plos.org
Helminth Trichinella spiralis (Ts) is one of the major pathogens of human infective
myocarditis that can lead to cardiac fibrosis (CF). The gut microbiota involved in this …

Recent advances of gut microbiota in chronic kidney disease patients

YY Zhao - Exploration of Medicine, 2022 - explorationpub.com
Chronic kidney disease (CKD) is a worldwide public health issue and has ultimately
progressed to an end-stage renal disease that requires life-long dialysis or renal …

Natural polysaccharides as potential anti-fibrotic agents: A review of their progress

M Wang, S Lu, H Zhao, Z Liu, K Sheng, J Fang - Life Sciences, 2022 - Elsevier
Fibrosis, as a common disease which could be found in nearly all organs, is normally
initiated by organic injury and eventually ended in cellular dysfunction and organ failure …

The differential crosstalk of the skin–gut microbiome axis as a new emerging actor in systemic sclerosis

E Russo, S Bellando-Randone, D Carboni… - …, 2024 - academic.oup.com
Objectives We characterized the microbiota in SSc, focusing on the skin–oral–gut axis and
the serum and faecal free fatty acid (FFA) profile. Methods Twenty-five SSc patients with …

Clostridium butyricum and Bifidobacterium pseudolongum attenuate the development of cardiac fibrosis in mice

J Wang, J Chen, L Li, H Zhang, D Pang… - Microbiology …, 2022 - Am Soc Microbiol
Cardiac fibrosis is an integral aspect of every form of cardiovascular diseases, which is one
of the leading causes of death worldwide. It is urgent to explore new effective drugs and …

[HTML][HTML] 肠道菌群及其代谢产物对心肌纤维化影响与治疗的研究进展

王喜文, 郑佳, 汤漾, 喻婵, 徐松 - 微生物学报, 2023 - actamicro.ijournals.cn
心肌纤维化是多种心血管疾病, 如冠心病, 心肌梗死和心力衰竭等的终末期表现和主要致病因素.
研究发现, 免疫和炎症过程在心肌纤维化的发病机制中起决定性作用. 近年来 …

Evaluation of the contribution of gut microbiome dysbiosis to cardiac surgery-associated acute kidney injury by comparative metagenome analysis

Y Li, X Jiang, J Chen, Y Hu, Y Bai, W Xu, L He… - Frontiers in …, 2023 - frontiersin.org
Introduction Cardiac surgery-associated acute kidney injury (CSA-AKI) is a common hospital-
acquired AKI that carries a grave disease burden. Recently, gut-kidney crosstalk has greatly …

[HTML][HTML] The gut-peritoneum Axis in peritoneal dialysis and peritoneal fibrosis

N Stepanova - Kidney Medicine, 2023 - Elsevier
Peritoneal fibrosis is an important cause of peritoneal dialysis (PD) discontinuation
worldwide and is associated with high morbidity and mortality rate. Although the era of …